Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

22nd Century Group Inc. (XXII)

2.88 -0.05 (-1.71%)

10-19 16:00

Open:

2.86

Pre. Close:

2.93

High:

2.985

Low:

2.86

Volume:

1,467,221

Market Cap:

358M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.983 - 2.999

2.999 - 3.013

Low:

2.821 - 2.841

2.841 - 2.858

Close:

2.85 - 2.88

2.88 - 2.906

Technical analysis  (as of: 2018-10-19 4:40:49 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 3.52     One year: 3.84

Support:

Support1: 2.56    Support2: 2.13

Resistance:

Resistance1: 3.01    Resistance2: 3.29

Pivot:

2.85

Moving Averages:

MA(5): 2.94     MA(20): 2.83

MA(100): 2.56     MA(250): 2.56

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.07

%K %D:

%K(14,3): 53.42     %D(3): 56.32

RSI:

RSI(14): 53.14

52-Week:

High: 4.44  Low: 1.921  Change(%): 3.6

Average Vol(K):

3-Month: 199562  10-Days 355496

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
XXII has closed below upper band by 44.8%. Bollinger Bands are 32.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-10-12T10:20:00-04:00
FDA Lead Scientist Discusses 22nd Century's SPECTRUM® Research Cigarettes in Public Webcast

2018-10-12T09:27:54-04:00
Premarket Gainers as of 9:05 am (10/12/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

124.37

Shares Float (M)

114.76

% Held by Insiders

7.70

% Held by Institutions

19.80

Shares Short (K)

17455

Shares Short Prior Month (K)

Stock Financials

EPS

-0.070

EPS Est. Current Year

-0.100

EPS Est. Next Year

-0.070

EPS Est. Next Quarter

-0.020

Forward EPS

-0.110

Book Value (p.s.)

5.210

PEG Ratio

Profit Margin

-47.90

Operating Margin

-81.08

Return on Assets (ttm)

-23.0

Return on Equity (ttm)

-25.5

Qtrly Rev. Growth

77.4

Gross Profit (p.s.)

-0.003

Sales Per Share

EBITDA (p.s.)

-0.025

Qtrly Earnings Growth

Operating Cash Flow (M)

-13.41

Levered Free Cash Flow (M)

-8.24

Valuation

P/E

-41.14

P/E Growth Ratio

-0.02

P/BV

0.55

P/S

1791072128.00

P/CF

-26.71

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.